Selecting an attorney for legal cases is a very important decision. Please enter your information below to receive a Free Consultation from an attorney in your area:
Drug Litigation News
FDA Commemorates a Century of Protecting and Promoting Public Health
The U.S. Food and Drug Administration (FDA) today will celebrate the centennial of the Pure Food and Drugs Act of 1906 at an event dedicated to the agency's past, present and future service to the nation. The ceremony, which will be held at the FDA's Harvey W. Wiley federal building, will feature U.S. Health and Human Services Secretary Michael O. Leavitt and Acting FDA Commissioner Andrew C. von Eschenbach, M.D. Also in attendance will be senior leaders of the agency, and scores of current and former FDA employees and special guests including former Commissioners of Food and Drugs, representatives of consumer and trade groups, and descendants of Dr. Harvey W. Wiley, the scientist whose early support of food and drug regulations earned him the title of "Father of the Pure Food and Drugs Act.
Dr. Wiley served as the first director of the Bureau of Chemistry of the United States Department of Agriculture, which later became the FDA. In addition to presentations by Secretary Leavitt and Acting Commissioner Dr. von Eschenbach, the program's highlights include an overview of the coming public health opportunities and challenges by FDA's Deputy Commissioners and other senior leaders of the agency. Sean K. Sullivan, Associate Publisher of Good Housekeeping magazine, will speak about Dr. Wiley's work following government service as Director of the Bureau of Foods, Sanitation and Health for Good Housekeeping magazine.
The modern FDA dates its origin to June 1906, when President Theodore Roosevelt signed the Food and Drugs Act and Congress embarked on a policy of continuous strengthening of public health protections and of their enforcement, first by the Bureau of Chemistry, and later by the FDA. Since then, Americans have benefited from increasingly comprehensive, science-based safeguards for a myriad products essential for health, survival and high quality of life.
Drug companies spend more on marketing than R&D
The top 10 drug companies spent nearly three times more on marketing, public relations and administration than they did on research and development.
Newsroom
News about Drug Litigation cases in Indiana and nationwide:
Pending Generic Drug Applications
If a patent is listed in the "Orange Book," an applicant seeking approval for an ANDA must submit a certification to the patent. Even an applicant ... Read more >
Definition:
A review is the basis of FDA's decision to approve a new drug application.
Product Number
Definition:
A product number is assigned to each drug product associated with an NDA (New Drug Application). If a drug product is available in multiple strengths, there are multiple product numbers.
Brand Name Drug
Definition:
A brand name drug is a drug marketed under a proprietary, trademark-protected name.
Legal Disclaimers All attorney listings are a paid attorney advertisement, and do not in any way constitute a referral or endorsement by an approved or authorized lawyer referral service. The information provided on Indiana Drug Litigation.com is not intended to be legal advice, but merely conveys
general information related to legal issues commonly encountered. Your access
to and use of this website is subject to additional Terms
and Conditions.
Local Professional? Generate new business today
Call 866-227-9356 or contact a sales rep
Did You Know?